Sensory organs

Evaluation of the effectiveness of the combination of drugs Dorzamed and timolol 0.5% in the treatment of primary open-angle glaucoma
Published in a journal «Ophthalmological Journal» № 2’2016
Clinical efficacy of an integrated approach in the treatment of refractive amblyopia with mixed astigmatism
VI Scientific and Practical Conference of Pediatric Ophthalmologists of Ukraine with International Participation '2015
Rational therapy for acute otitis media
Published in a medical journal «Health of Ukraine of the 21st century» № 7 (308)’2013
How to maintain healthy vision?
Published in the journal «Pharmacy Navigator» № 5’2013
Possibilities of using WORLD MEDICINE drugs in complex pharmacological support of cataract surgery
Published in a journal «Ophthalmological Journal» № 4’2013
Comparison of the effect of topical application of dexamethasone and diclofenac on the process of corneal epithelialization after a burn
Published in the journal «Ophthalmology Journal» № 3’2013
The effectiveness of the use of ciprofloxacin and tobramycin in the treatment of neonatal dacryocystitis and acute bacterial conjunctivitis in young children
Published in the journal «Ophthalmology Journal» № 6’2012
Study of the sensitivity of microflora during eye burns to antibacterial drugs «Floximed» and «Tobrimed»
Published in a journal «Ophthalmological Journal» № 4’2012
The effectiveness of drugs ciprofloxacin and tobramycin in the treatment of traumatic keratitis
Published in the journal «Ophthalmology Journal» № 3’2012
Study of the analgesic effect of diclofenac sodium eye drops during panretinal laser coagulation in patients with diabetic retinopathy
Published in a journal «Ophthalmological Journal» № 3’2012

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design